- Home
- BEEM vs PSTV Comparison
BEEM vs PSTV Comparison
Compare BEEM & PSTV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | BEEM | PSTV |
|---|---|---|
| Founded | 2006 | 1996 |
| Country | United States | United States |
| Employees | 276 | N/A |
| Industry | Semiconductors | Medical/Dental Instruments |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 29.1M | 27.9M |
| IPO Year | N/A | 2016 |
Fundamental Metrics
Financial Performance| Metric | BEEM | PSTV |
|---|---|---|
| Price | $1.46 | $3.62 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 4 | 4 |
| Target Price | $3.50 | ★ $7.67 |
| AVG Volume (30 Days) | 189.6K | ★ 4.5M |
| Earning Date | 05-14-2026 | 03-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 87.61 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $5,213,000.00 |
| Revenue This Year | N/A | $21.93 |
| Revenue Next Year | $49.29 | $279.39 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $1.33 | $0.13 |
| 52 Week High | $4.04 | $3.81 |
Technical Indicators
Market Signals| Indicator | BEEM | PSTV |
|---|---|---|
| Relative Strength Index (RSI) | 49.00 | 96.29 |
| Support Level | $1.47 | $0.37 |
| Resistance Level | $1.66 | N/A |
| Average True Range (ATR) | 0.06 | 0.05 |
| MACD | 0.01 | 0.21 |
| Stochastic Oscillator | 72.97 | 93.21 |
Price Performance
Historical ComparisonAbout BEEM Beam Global
Beam Global produces sustainable technology for electric vehicle (EV) charging, outdoor media, and energy security, without the construction, disruption, and costs of grid-tied solutions. Its products are founded upon its patented EV ARC and Solar Treelines and include BeamTrak patented solar tracking, and ARC Technology energy storage, along with EV charging, outdoor media, and disaster preparedness packages. From start to finish, the company develops, patents, designs, engineers, and manufactures renewably energized products that help the environment, empower communities, and keep people moving.
About PSTV PLUS THERAPEUTICS Inc.
Plus Therapeutics Inc is a clinical-stage pharmaceutical company that focuses on discovering, developing, commercializing and delivering complex treatments for patients with cancer and rare diseases. The company is working on a range of potential products, with its main programs targeting recurrent glioblastoma (GBM) and leptomeningeal metastases (LM). One of its key candidates, rhenium (186Re) obisbemeda, is specifically designed to treat central nervous system (CNS) cancers such as GBM, LM, and pediatric brain cancers (PBC).